• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Jack Buzby, USA

    Jack Buzby, USA

  • Inta Grubb, Australia

    Inta Grubb, Australia

  • Rosie Riley, USA

    Rosie Riley, USA

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Lombana, Spain

    Lombana, Spain

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Oscar Mauricio Linares, Colombia

    Oscar Mauricio Linares, Colombia

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Liam Dwyer, England

    Liam Dwyer, England

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Daniel Hare, USA

    Daniel Hare, USA

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Luis Antonio Pimenta Lima, Brazil

    Luis Antonio Pimenta Lima, Brazil

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Jon Newsome, USA

    Jon Newsome, USA

  • Anna Barrow, UK

    Anna Barrow, UK

  • Ada Garrido Benavidez, Mexico

    Ada Garrido Benavidez, Mexico

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Susan Anderson, USA

    Susan Anderson, USA

  • Christian Bär, Germany

    Christian Bär, Germany

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Anita Forte, USA

    Anita Forte, USA

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Bob Simonds, USA

    Bob Simonds, USA

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Lee Millard, England

    Lee Millard, England

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • Torben Mikkelsen, Denmark

    Torben Mikkelsen, Denmark

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login